Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
State Street SPDR S&P Biotech ETF
(NY:
XBI
)
122.86
-0.32 (-0.26%)
Official Closing Price
Updated: 8:00 PM EST, Feb 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8,804,970
Open
123.60
Bid (Size)
122.36 (800)
Ask (Size)
122.86 (900)
Prev. Close
123.18
Today's Range
122.50 - 126.10
52wk Range
66.66 - 132.09
Shares Outstanding
541,500
Dividend Yield
1.33%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
IBRX Stokes Retail Chatter — Investors See Anktiva Beat Merck’s Keytruda With Approval In EU
↗
February 13, 2026
Retail investors are now looking forward to a full approval of Anktiva in the EU for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ.
Via
Stocktwits
RARE Stock Slumps On Multiple Wall Street Price Target Slashes, Clinical Pipeline Uncertainty
↗
February 13, 2026
Ultragenyx said on Thursday that the FDA has again refused approval for UX111 in the treatment of Sanfilippo syndrome type A.
Via
Stocktwits
Performance
YTD
+1.1%
+1.1%
1 Month
-1.2%
-1.2%
3 Month
+7.0%
+7.0%
6 Month
+36.2%
+36.2%
1 Year
+34.4%
+34.4%
More News
Read More
VKTX Stock Rallies After Hours On Optimism Around Company’s Obesity Pipeline
↗
February 11, 2026
Via
Stocktwits
Biotech Beat Nvidia in 2025. Can It Do It Again?
↗
February 11, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Why IBRX Stock Is One Of The Biggest Pre-Market Movers Today
↗
January 16, 2026
Via
Stocktwits
IBRX Stock Finds Retail Cheer After Company’s Immunotherapy For Bladder Cancer Gets Saudi FDA Approval
↗
January 14, 2026
Via
Stocktwits
Why Did NRXP Stock Surge 21% Pre-Market Today?
↗
January 14, 2026
Via
Stocktwits
Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now
↗
February 11, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Economy
Why Did UPB Stock Pop 20% In Pre-Market Today?
↗
February 11, 2026
Via
Stocktwits
Why Did RGNX Shares Plummet 19% After-Hours Today?
↗
February 09, 2026
Via
Stocktwits
MDXG Stock Rises As MiMedx Enters Into Exclusive Distribution Agreement For Three Products
↗
February 04, 2026
Via
Stocktwits
Topics
Artificial Intelligence
IBRX Garners Retail Attention On Positive Update In Immunotherapy For Lung Cancer Patients
↗
January 13, 2026
Via
Stocktwits
Why Did TVTX Stock Crash 30% In Pre-Market Today?
↗
January 13, 2026
Via
Stocktwits
IMRX Stock Closed Over 20% Higher Today: Here’s Why
↗
January 07, 2026
Via
Stocktwits
RGNX Stock Is Falling Today — What Is The FDA Update On REGENXBIO's Gene Therapy?
↗
January 28, 2026
Via
Stocktwits
Why Did MNKD Stock Jump Over 7% In Pre-Market Today?
↗
January 26, 2026
Via
Stocktwits
The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market
January 22, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Initial Public Offering
Why NVAX Stock Is Popping Pre-Market – And What Does Pfizer Have To Do With It?
↗
January 20, 2026
Via
Stocktwits
Why Did GLUE Stock Surge Over 50% In Premarket Today?
↗
January 07, 2026
Via
Stocktwits
Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution
December 09, 2025
Via
MarketMinute
Topics
ETFs
Economy
Intellectual Property
Eaton, FTAI Aviation And More On CNBC's 'Final Trades'
↗
November 28, 2025
Via
Benzinga
Topics
ETFs
Stocks
Biotech Insiders Are Spending Billions. Trump Favors Less Oversight. One Biotech ETF Could Ride the Surge.
↗
November 17, 2025
Via
The Motley Fool
Topics
ETFs
Economy
Government
Money Moving Into Healthcare Not AI; Four Fed Presidents Do Not Want a Rate Cut; Euphoria Wearing Off
↗
November 13, 2025
Via
Benzinga
Topics
Economy
Taiwan Semiconductor, HealthEquity, Cboe Global Markets And More: CNBC's 'Final Trades'
↗
November 13, 2025
Via
Benzinga
Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over?
↗
November 03, 2025
Via
Benzinga
Topics
ETFs
Frequently Asked Questions
Is State Street SPDR S&P Biotech ETF publicly traded?
Yes, State Street SPDR S&P Biotech ETF is publicly traded.
What exchange does State Street SPDR S&P Biotech ETF trade on?
State Street SPDR S&P Biotech ETF trades on the New York Stock Exchange
What is the ticker symbol for State Street SPDR S&P Biotech ETF?
The ticker symbol for State Street SPDR S&P Biotech ETF is XBI on the New York Stock Exchange
What is the current price of State Street SPDR S&P Biotech ETF?
The current price of State Street SPDR S&P Biotech ETF is 122.86
When was State Street SPDR S&P Biotech ETF last traded?
The last trade of State Street SPDR S&P Biotech ETF was at 02/13/26 08:00 PM ET
What is the market capitalization of State Street SPDR S&P Biotech ETF?
The market capitalization of State Street SPDR S&P Biotech ETF is 66.53M
How many shares of State Street SPDR S&P Biotech ETF are outstanding?
State Street SPDR S&P Biotech ETF has 67M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today